Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-05-18 GRIFFIN MICHELLE RENEE Director Option exercise · Stock Option (Right to Buy) −2,500 76,000
2021-05-18 Palaniappan Jyoti SVP, Diagnostics, T-Detect Option exercise +651 $22.55 $15K 9,809
2021-05-18 Palaniappan Jyoti SVP, Diagnostics, T-Detect Sale −651 $35.00 $23K 9,158
2021-05-18 Palaniappan Jyoti SVP, Diagnostics, T-Detect Option exercise · Stock Option (Right to Buy) −651 106,996
2021-05-17 THORSEN HENNING SVP, Commercial Operations Grant or award +29,061 29,061
2021-05-17 THORSEN HENNING SVP, Commercial Operations Grant or award · Stock Option (Right to Buy) +72,653 72,653
2021-05-14 LO FRANCIS Chief People Officer Option exercise +2,000 $7.80 $16K 22,604
2021-05-14 LO FRANCIS Chief People Officer Sale −2,000 $33.80 $68K 20,604
2021-05-14 LO FRANCIS Chief People Officer Option exercise · Stock Option (Right To Buy) −2,000 151,000
2021-05-12 Cohen Chad M Chief Financial Officer Option exercise +10,000 $6.55 $66K 31,604
2021-05-12 Cohen Chad M Chief Financial Officer Sale −10,000 $32.63 $326K 21,604
2021-05-12 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −10,000 130,000
2021-05-11 Cohen Chad M Chief Financial Officer Option exercise +10,000 $6.55 $66K 31,604
2021-05-11 Cohen Chad M Chief Financial Officer Sale −2,969 $30.81 $91K 28,635
2021-05-11 Cohen Chad M Chief Financial Officer Sale −7,031 $31.84 $224K 21,604
2021-05-11 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −10,000 140,000
2021-05-06 ROBINS HARLAN S Chief Scientific Officer Option exercise +3,895 $6.32 $25K 73,255
2021-05-06 ROBINS HARLAN S Chief Scientific Officer Sale −3,048 $35.51 $108K 70,207
2021-05-06 ROBINS HARLAN S Chief Scientific Officer Sale −847 $36.38 $31K 69,360
2021-05-06 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −3,895 128,535

Page 47 of 120 · 2,386 trades